Six-month changes in ghrelin and glucagon-like peptide-1 with weight loss are unrelated to long-term weight regain in obese older adults

被引:0
|
作者
Jared J. Rejeski
Jason Fanning
Barbara J. Nicklas
W. Jack Rejeski
机构
[1] Department of Internal Medicine,Department of Health & Exercise Science
[2] Section on Gastroenterology,undefined
[3] Wake Forest School of Medicine,undefined
[4] Wake Forest University,undefined
[5] Department of Internal Medicine,undefined
[6] Section on Gerontology and Geriatric Medicine,undefined
[7] Wake Forest School of Medicine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:888 / 894
页数:6
相关论文
共 50 条
  • [1] Six-month changes in ghrelin and glucagon-like peptide-1 with weight loss are unrelated to long-term weight regain in obese older adults
    Rejeski, Jared J.
    Fanning, Jason
    Nicklas, Barbara J.
    Rejeski, W. Jack
    INTERNATIONAL JOURNAL OF OBESITY, 2021, 45 (04) : 888 - 894
  • [2] Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects
    de Luis, D. A.
    Gonzalez Sagrado, M.
    Conde, R.
    Aller, R.
    Izaola, O.
    ANNALS OF NUTRITION AND METABOLISM, 2007, 51 (02) : 134 - 138
  • [3] Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects
    Näslund, E
    King, N
    Mansten, S
    Adner, N
    Holst, JJ
    Gutniak, M
    Hellström, PM
    BRITISH JOURNAL OF NUTRITION, 2004, 91 (03) : 439 - 446
  • [4] Effect of dramatic weight loss on peptide YY and glucagon-like peptide-1 serum levels in morbidly obese patients
    Schernthaner, Guntram
    Kopp, Hans P.
    Schernthaner, Gerit H.
    Kriwanek, Stefan
    Roth, Christian
    Reinehr, Thomas
    DIABETES, 2007, 56 : A71 - A71
  • [5] Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss
    Reinehr, Thomas
    Roth, Christian L.
    Schernthaner, Gerit-Holger
    Kopp, Hans-Peter
    Kriwanek, Stefan
    Schernthaner, Guntram
    OBESITY SURGERY, 2007, 17 (12) : 1571 - 1577
  • [6] Peptide YY and Glucagon-like Peptide-1 in Morbidly Obese Patients Before and After Surgically Induced Weight Loss
    Thomas Reinehr
    Christian L. Roth
    Gerit-Holger Schernthaner
    Hans-Peter Kopp
    Stefan Kriwanek
    Guntram Schernthaner
    Obesity Surgery, 2007, 17
  • [7] Ghrelin, glucagon-like peptide-1, and peptide YY secretion in patients with and without weight regain during long-term follow-up after bariatric surgery: a cross-sectional study
    Lampropoulos, Charalampos
    Mulita, Francesk
    Alexandrides, Theodoros
    Kehagias, Dimitrios
    Kalavrizioti, Dimitra
    Albanopoulos, Konstantinos
    Georgopoulos, Neoklis
    Papachristou, Evangelos
    Kehagias, Ioannis
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2022, 21 (02): : 97 - 105
  • [8] Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in the Weight Loss Among Obese Individuals: A Systematic Review
    Aldahash, Raed
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2021, 11 (05) : 95 - 107
  • [9] Fasting glucagon-like peptide-1 and its relation to insulin in obese children before and after weight loss
    Reinehr, Thomas
    de Sousa, Gideon
    Roth, Christian L.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 44 (05): : 608 - 612
  • [10] The Long-Term Effect of Glucagon-Like Peptide 1 Receptor Agonists on Glycemic Control Is Predominantly Related to Weight Loss
    Al-Badri, Marwa
    Dhaver, Shilton E.
    Salah, Tareq
    Kibaa, Karim
    Khater, Abdelrahman
    Mccarragher, Ryan
    Demattos, Lily
    Al-Roomi, Fatimah
    Hamdy, Osama
    DIABETES, 2023, 72